The role of fetal microchimerism in autoimmune disease

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 2, 2010, Pages 164-168

  Miech, Ralph P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Abortion; Autoimmune disease; Microchimerism; Pathophysiology

Indexed keywords

DNA;

ARTICLE; AUTOIMMUNE DISEASE; FETAL MICROCHIMERISM; FIRST TRIMESTER PREGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; MEDICAL ABORTION; MICROCHIMERISM; NONHUMAN; PLACENTAL TRANSFER; PRE T LYMPHOCYTE; PREGNANCY TERMINATION; RISK FACTOR; SECOND TRIMESTER ABORTION; SURGICAL ABORTION;

EID: 77955524664     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev 2008;7(8):626-30.
2. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis 2004;10(11):2005-11.
3. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2 (3):119-25.
4. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2(9):777-80.
5. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, and Loscalzo J, Eds. Autoimmunity and Autoimmune Diseases. Harrison's Online: Harrison's Principles of Internal Medicine, 17e, Chapter 312.
6. Pendergraft JS. Autoimmune diseases-causes, symptoms and treatments. http://ezinearticles.com/?Autoimmune-Diseases-Causes,-Symptoms-andtreatments&id=1920321.
7. Nelson, JL. Your cells are my cells. Sci Am 2008;298(2):64-7
8. Nelson, JL. Microchimerism and Autoimmune Disease. JAMA 1998;338(17):1223-1225.
9. Lo YM, Lau TK, Chan LY, Leung TN, Chang AM. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46(9):1301-9.
10. IMAMURA S, SATO A, OTO H. Pregnancy Induced Microchimerism. http://sciencelinks.jp/j-east/article/200123/000020012301A0695384.php Fukushima Med J 2001;51(2).113-119.
11. O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IA. Fisk NM. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004 Jul 10-16;364(9429):179-82.
12. Adams Waldorf KM, Nelson JL. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest 2008;37(5):631-44.
13. van Rood JJ, Roelen DL, Claas, FHJ. The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol 2005; 42 (2):104-111.
14. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood. 1999;93 (6):2033-7.
15. Stevens AM. Do maternal cells trigger or perpetuate autoimmune diseases in children? Pediatr Rheumatol Online J 2007;5:9.
16. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood. 1996;88(11):4390-5.
17. Gilliam AC. Microchimerism and skin disease: true-true unrelated? J Invest Dermatol. 2006;126(2):239-41.
18. Loubière LS, Lambert NC, Flinn LJ, Erickson TD, Yan Z, Guthrie KA, Vickers KT, Nelson JL. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells. Lab Invest. 2006;86(11):1185-92.
19. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001;41(12):1524-30.
20. Shields LE, Andrews RG. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol 1998;178(5):931-7.
21. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98(8):2396-402.
22. Aractingi S, Uzan S, Dausset J, Carosella ED. Microchimerism in human diseases. Immunol Today. 2000;21(3):116-8.
23. Sato T, Fujimori K, Sato A, Ohto H. Microchimerism after induced or spontaneous abortion. Obstet Gynecol 2008;112(3):593-7.
24. Klonisch T, Drouin R. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Med. 2009;15(11):510-8.
25. Gannagé M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S. Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol 2002;32(12):3405-13.
26. Hromadnikova I, Zlacka D, Hien Nguyen TT, Sedlackova L, Zejskova L, Sosna A. Fetal cells of mesenchymal origin in cultures derived from synovial tissue and skin of patients with rheumatoid arthritis. Joint Bone Spine 2008;75 (5):563-6.
27. Johnson KL, Bianchi DW. Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update. 2004;10(6):497-502.
28. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351(9102):559-62.
29. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996;93 (2):705-8.
30. Lissauer D, Piper KP, Moss PA, Kilby MD. Persistence of fetal cells in the mother: friend or foe? BJOG 2007;114(11):1321-5.
31. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004;292(1):75-80.
32. Apari P, Rózsa L. The tripartite immune conflict in placentals and a hypothesis on fetal maternal microchimerism. Med Hypotheses 2009;72(1):52-4.
33. Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996;39(2):191-4.
34. Nelson JL. Naturally acquired microchimerism: for better or for worse. Arthritis Rheum 2009;60(1):5-7.
35. J. Lee Nelson. Research interests. http://www.gs.washington.edu/faculty/jnelson.htm
36. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev. 2004;3(6):454-63.
37. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004;291(9):1127-31.
38. Nelson JL. Microchimerism in human health and disease. Autoimmunity 2003;36(1):5-9.
39. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun Rev. 2003;2(3):133-9.
40. Nelson JL. Pregnancy and microchimerism in autoimmune disease: protector or insurgent? Arthritis Rheum 2002;46(2):291-7.
41. Stevens A, Nelson, J. Maternal and Fetal Microhhimerism: Implications for Human Diseases. NeoReviews 2002:3(11):e11-e19.
42. Nelson JL. Microchimerism and human autoimmune diseases. Lupus 2002;11 (10):651-4.
43. Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med 2002;8 (3):109-13.
44. Leduc M, Aractingi S, Khosrotehrani K. Fetal-cell microchimerism, lymphopoiesis, and autoimmunity. Arch Immunol Ther Exp (Warsz). 2009;57(5):325-9.
45. Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD, Nelson JL. Male DNA in female donor apheresis and CD34-enriched products. Blood 2003;102(10):3845-7.
46. Artlett CM. Pathophysiology of fetal microchimeric cells. Clin Chim Acta 2005;360 (1-2):1-8.
47. Ichinohe T, Teshima T, Matsuoka K, Maruya E, Saji H. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr Opin Immunol 2005;17(5):546-52.
48. Davidson A. Diamond B. Autoimmune Diseases. N Engl J Med. 2001;345(5):340-350.
49. Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, Yan Z, Azzouz D, Auger I, Roudier C, Martin M, Didelot R, Roudier J, Lambert NC. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009;60 (1):73-80.
50. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The Influence of Fetal Loss on the Presence of Fetal Cell Microchimerism. Arthritis Rheum 2003;48 (11):3237-41.
51. Klintschar M, Immel UD, Kehlen A, Schwaiger P, Mustafa T, Mannweiler S, Regauer S, Kleiber M, Hoang-Vu C. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol. 2006;154(2):237-41.
52. Ando T, Davies TF. Clinical Review 160: Postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. J Clin Endocrinol Metab.2003;88(7):2965-71.
53. Jameson, JL. Evidence for Fetal Microchimerism in Autoimmune Thyroid Disease. Harrison's Online: Harrison's Principles of Internal Medicine, 17e, Chapter 320 9/4/2002.
54. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, Klinger KW. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol. 2001;184(4):703-6.
55. Nemescu, D; Onofriescu, M. The impact of fetal cells persistence in maternal organism. GINECO RO 2008;4(4):212-216.
56. Yan Z, Lambert NC, Guthrie KA, Porter AJ, Loubiere LS, Madeleine MM, Stevens AM, Hermes HM, Nelson JL. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005;118(8):899-906.
57. Johnson KL, Tao K, Stroh H, Kallenbach L, Peter I, Richey L, Rust D, Bianchi DW. Increased fetal cell trafficking in murine lung following complete pregnancy loss from exposure to lipopolysaccharide. Fertil Steril 2010;93 (5):1718-1721.
58. McGrath H Jr. Elective pregnancy termination and microchimerism: Comment on the article by Khosrotehrani et al. Arthritis Rheum 2004;50 (9):3058-9; author reply 3059.